Company Information

Company Pfizer, Inc.
pfizer.com
Type:
Company
Country:
United States of America
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Publicly Listed
Global Compact Status:
Active
Participant Since
04 October 2002
Next Communication on Progress (COP) due on:
31 July 2024

Financial Information


Non-Financial Information

Affiliated Subsidiaries

Country Company Name
Austria Pfizer Corporation Austria GmbH
United Kingdom Pfizer Ltd
Germany Pfizer Pharma GmbH
Mexico Pfizer S.A. de C.V.

Communication On Progress

Published On Title Level/Status
22-Jul-2022 Communication on Progress Active
20-Aug-2021 2021 Communication on Progress Active
08-Sep-2020 Communication on Progress Active
20-Sep-2019 Communication on Progress Active
28-Jun-2018 2018 Communication on Progress Active
28-Jun-2017 2017 Communication on Progress Active
30-Jun-2016 Communication on Progress 2016 Active
01-Jul-2015 Communication on Progress 2015 Active
16-Jul-2014 Communication on Progress Active
16-Jul-2013 Communication on Progress Active
23-Jul-2012 Communication on Progress Active
22-Aug-2011 2011 Communication on Progress Active
20-Sep-2010 2010 Communication on Progress Not applicable
20-Oct-2009 Pfizer 2009 Corporate Responsibility Report Not applicable
09-Dec-2008 Corporate Responsibility Report Not applicable
10-Dec-2007 Strong Actions: Partnerships for Positive Change Not applicable
29-Dec-2006 Pfizer Inc Annual Communication on Progress Not applicable
13-Jul-2005 Communication on Progress 2005 Not applicable
18-Jun-2004 Communications Report 2003-2004 Not applicable

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.